-
Article
Does previous transurethral resection of the prostate affect the outcomes in robotic assisted radical prostatectomy?
Transurethral resection of the prostate (TURP) is one of the surgical options for treating enlarged prostates with lower urinary symptoms (LUTS). In this older group of patients, concomitant prostate cancer is...
-
Article
Clinical applications of robotic surgery platforms: a comprehensive review
Robotic surgery has expanded globally across various medical specialties since its inception more than 20 years ago. Accompanying this expansion were significant technological improvements, providing tremendou...
-
Chapter
Nerve Sparing Techniques in Robot-Assisted Radical Prostatectomy
Cancer prostate is the most commonly diagnosed cancer as well as the second most common cause of death in the United States of America. In 2009, as many 192,280 (25%) men were estimated as new diagnosis with p...
-
Article
Simultaneous hernia repair following robotic-assisted radical prostatectomy is safe with low rates of mesh-related complications
Robotic-assisted radical prostatectomy (RARP) is the gold-standard treatment for localized prostate cancer in the USA. However, performing RARP along with a concomitant hernia repair with mesh is debatable bec...
-
Article
Impact of human placental derivative allografts on functional and oncological outcomes after radical prostatectomy: a literature review
Post radical prostatectomy (RP) erectile dysfunction and incontinence impacts quality of life for patients. In an objective to hasten the recovery of these functional outcomes, human placental derived allograf...
-
Article
Correction to: Does type of robotic platform make a difference in the final cost of robotic-assisted radical prostatectomy?
-
Article
Does type of robotic platform make a difference in the final cost of robotic-assisted radical prostatectomy?
This study evaluates the difference of robot-assisted radical prostatectomy (RARP) costs in patients with similar preoperative characteristics operated on using the da Vinci® SP and ** robotic platforms. We perfo...
-
Article
Nerve spare robot assisted laparoscopic prostatectomy with amniotic membranes: medium term outcomes
dHACM is a source of factors including cytokines that allow anti-inflammatory and proliferative elements to be utilized for wound and ulcer management. We present our experience of using dHACM in a cohort of p...
-
Article
Robotic-assisted radical prostatectomy in young adults: age-stratified oncological and functional outcomes
There is a scarcity of information on the outcomes of robotic-assisted prostatectomy (RALP) in young men. To compare the age-stratified functional and oncological outcomes of RALP in men aged ≤ 55 years. Among...
-
Article
Patient surgical satisfaction after da Vinci® single-port and multi-port robotic-assisted radical prostatectomy: propensity score-matched analysis
The da Vinci® single-port (SP) and multiport (**) approaches to robotic-assisted radical prostatectomy (RARP) are described by different authors in the literature, primarily comparing short-term outcomes of both ...
-
Chapter
Preparation of the Operating Room, Back Table, and Surgical Team
In order for hospitals and physicians to remain competitive, ongoing training and the use of new technology are necessary to keep pace with the ever-evolving healthcare world. Robotic surgery is a perfect exam...
-
Article
Da Vinci SP platform updates and modifications: the first impression of new settings
-
Article
Evidence-based evolution of our robot-assisted laparoscopic prostatectomy (RALP) technique through 13,000 cases
Robot-assisted laparoscopic radical prostatectomy (RALP) has become the standard of surgical care in the USA and around the world. Over the past 18 years, we have performed 13,000 radical prostatectomies, and ...
-
Article
COVID-19 model-based practice changes in managing a large prostate cancer practice: following the trends during a month-long ordeal
Coronavirus (COVID-19) has been a life-changing experience for both individuals and institutions. We describe changes in our practice based on real-time assessment of various national and international trends ...
-
Article
Use of transversus abdominis plane block to decrease pain scores and narcotic use following robot-assisted laparoscopic prostatectomy
The aim of this study was to assess whether transversus abdominis plane (TAP) blocks can be utilized to decrease patient pain scores and narcotic use during the first 24 h following robot-assisted laparoscopic...
-
Article
The ongoing dilemma in pelvic lymph node dissection during radical prostatectomy: who should decide and in which patients?
Pelvic lymph node dissection (pLND) is considered the most reliable method for the detection of lymph node metastases in prostate cancer. Current clinical guidelines recommend performing pLND in intermediate- ...
-
Article
Can we predict who will need lymphocele drainage following robot assisted laparoscopic prostatectomy (RALP)?
Pelvic lymph node dissection (PLND) can cause lymphoceles. Lymphocele formation following PLND can reach up to 60% and are symptomatic in 0.4 to 16% of patients. The aim of the study was to identify factors th...
-
Article
Robotic radical prostatectomy with concomitant repair of inguinal hernia: is it safe?
Robotic radical prostatectomy (RARP) is well established as a safe and effective treatment for prostate cancer. According to published studies, patients undergoing RARP are at increased risk of being diagnosed...
-
Article
Can dehydrated human amnion/chorion membrane accelerate the return to potency after a nerve-sparing robotic-assisted radical prostatectomy? Propensity score-matched analysis
The objective of this study is to determine if the use of dehydrated human amnion/chorion membrane (dHACM) allograft wrapped around the NVB during a robotic-assisted radical prostatectomy (RARP) accelerates th...
-
Chapter
Techniques of Nerve Sparing in Robot-Assisted Radical Prostatectomy
Cancer prostate is the most commonly diagnosed cancer as well as the second most common cause of death in the United States of America. In 2009, as many 192,280 (25%) men were estimated as new diagnosis with p...
